Concepedia

Publication | Open Access

PIM Kinase Inhibitor AZD1208 for Treatment of MYC-Driven Prostate Cancer

DOIFull Paper Access

86

Citations

38

References

2014

Year

Austin N. Kirschner, Jie Wang, Riet van der Meer, Philip D. Anderson, Omar E. Franco-Coronel, Max H. Kushner, Joel H. Everett, Omar Hameed, Erika Krasnickas Keeton, Miika Ahdesmäki,
JNCI Journal of the National Cancer Institute

Abstract

PIM inhibition is a potential treatment for MYC-driven prostate cancers including CRPC, and its effectiveness may be enhanced by activators of the p53 pathway, such as radiation.

References

YearCitations

Page 1